New York Cancer & Blood Specialists Partners with Canopy to Enhance Patient Outcomes Through Continuous Care Management
NEW YORK, Sept. 7, 2023 /PRNewswire/ -- New York Cancer & Blood Specialists (NYCBS), one of the nation's leading oncology...
Medicare
Arcadia Earns Validated Data Stream Designation From NCQA
Achievement expedites quality reporting and boosts audit compliance by proving data accuracy BOSTON, Sept. 7, 2023 /PRNewswire/ -- Arcadia (Arcadia.io),...
New FAIR Health Study Examines Use of Telehealth in Connecticut from 2020 to 2022
Over 90 Percent of Connecticut Patients Used Telehealth to See Healthcare Providers Whom They Also Saw in Person NEW YORK,...
Infirmary Health Adopts Wellbox Chronic Care Management, Expanding Patient Access to Virtual Care
JACKSONVILLE, FL / ACCESSWIRE / September 7, 2023 / Wellbox, a population health company focused on improving outcomes in chronically...
Therma Bright Submits Updated FDA 510K Application Requesting Correction of Venowave Device’s Intended Use, Labeling, and Description
Toronto, Ontario--(Newsfile Corp. - September 7, 2023) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer...
VitalPointTech Announces Acquisition of Herban Healing, LLC, a Revolutionary Bio-Pharmaceutical Company
Herban Healing is dedicated to providing alternative healthcare options to combat the opioid crisisHOUSTON, TX / ACCESSWIRE / August 29,...
CMS grants reimbursement code for the Polarean XENOVIEW™ MRI Technology
The code is effective as of October 1, 2023Durham, NC, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Polarean (AIM: POLX), a...
Better Life Partners Raises $26.5 Million in Series B Financing to Amplify and Scale its Hybrid Whole-Health Solutions for Substance Use Disorders
Funding will expand company’s technology-enabled, alternate-payment care model, bringing its innovative and effective approach to more people in needBOSTON, Aug....
Oncocyte’s VitaGraft Kidney Transplant Diagnostic Test Receives CMS Coverage
First digital-droplet PCR assay to receive coverageExpect initial revenue generation in Q1 2024IRVINE, CA / ACCESSWIRE / August 28, 2023...
CloudMD Reports Second Quarter 2023 CloudMD Continues to Drive Execution with Adjusted EBITDA Approaching Breakeven
Adjusted EBITDA1 loss of $0.7 million. This was CloudMD’s third consecutive quarter of improving Adjusted EBITDA, representing a $2.5 million...
BridgeBio presents detailed positive results from Phase 3 ATTRibute-CM study of acoramidis for patients with transthyretin amyloid cardiomyopathy (ATTR-CM) at European Society of Cardiology Congress 2023
- The primary endpoint was met (Win Ratio of 1.8) with a highly statistically significant p-value (p<0.0001); this primary endpoint...
Trinity Health Medicare ACOs Continue Savings for Eighth Year
LIVONIA, MI / ACCESSWIRE / August 25, 2023 / In calendar year 2022, Trinity Health Integrated Care (THIC) ACO, a...
MDxHealth Reports Q2 and Half Year 2023 Results
NEWS RELEASE – REGULATED INFORMATION23 AUGUST 2023, 4:00PM EDT / 22:00 CET MDxHealth Reports Q2 and Half Year...
Concert Health Joins athenahealth’s Marketplace Program to Give Providers and Patients Access to High-Quality Behavioral Health Services
Integration will allow healthcare providers to refer patients directly to Concert’s team of expert cliniciansSAN DIEGO--(BUSINESS WIRE)--#behavioralhealth--Concert Health, a leading...
Therma Bright Provides Update on Venowave’s Permanent CPT/HCPCS Code Application Process
Toronto, Ontario--(Newsfile Corp. - August 22, 2023) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer...
Hospice Dynamix and KanTime Announce a Strategic Partnership
MEMPHIS, Tenn.--(BUSINESS WIRE)--Hospice Dynamix, a leading provider of innovative predictive analytical software solutions for the hospice care industry, today announced...
EYLEA HD (aflibercept) Injection 8 mg Approved by FDA for Treatment of Wet Age-related Macular Degeneration (wAMD), Diabetic Macular Edema (DME) and Diabetic Retinopathy (DR)
Approval based on the pivotal PULSAR and PHOTON trials in which EYLEA® HD demonstrated clinically equivalent vision gains to EYLEA...
Pacific Health Care Organization, Inc. Reports its Results for the Period ended June 30, 2023
Irvine, Aug. 18, 2023 (GLOBE NEWSWIRE) -- Results The Company reported net income of $176,427 or $0.01 per basic and...
Odronextamab Receives EMA Filing Acceptance for Treatment of Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma
TARRYTOWN, N.Y., Aug. 17, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the European Medicines Agency...
Health Canada Grants Device License for iCAD’s ProFound Risk 2.0, Revolutionizing Breast Cancer Risk Via a 1-2 Year Assessment
NASHUA, N.H., Aug. 16, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer...